Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
about
Heterodimeric interaction and interfaces of S100A1 and S100PModulation of cardiac contractility by the phospholamban/SERCA2a regulatomeS100A1: a regulator of myocardial contractilityIdentification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA libraryMechanisms of altered Ca²⁺ handling in heart failureGene therapy targets in heart failure: the path to translationExtracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performanceImpaired cardiac contractility response to hemodynamic stress in S100A1-deficient miceS100A1 in human heart failure: lack of recovery following left ventricular assist device supportCardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal modelS100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapyTargeting S100A1 in heart failureS100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction couplingS100A1: Structure, Function, and Therapeutic PotentialS100A1 enhances the L-type Ca2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytesS100A1: a multifaceted therapeutic target in cardiovascular diseaseCardiac adenoviral S100A1 gene delivery rescues failing myocardiumInhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.Differential effects of S100 proteins A2 and A6 on cardiac Ca(2+) cycling and contractile performance.S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial functionModulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1.Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment.Gene delivery approaches to heart failure treatment.S100A1 (S100 calcium binding protein A1)Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy.Gene transfer for congestive heart failure: update 2013.S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.Regulation of Na+/Ca2+ exchange current in the normal and failing heart.S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction.Gene therapy in heart failure.Designing heart performance by gene transfer.Targeting sarcoplasmic reticulum calcium ATPase by gene therapy.S100B: a multifunctional role in cardiovascular pathophysiology.Gene therapy for ischemic heart disease.Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.The S100 protein family and its application in cardiac diseases.
P2860
Q24294738-86F0F09A-B61A-4213-8966-8064FD8B00F7Q24337593-0307E357-335D-42FC-B106-85EDA5CB1E08Q24555086-C44F3233-A108-4BAC-AFD2-58EB3767BDB5Q24621533-CAE49F3F-3A05-4491-8570-9D753D5DDB01Q27012758-33C97466-859C-4F36-B803-D7E509A59B8AQ27022444-2FC97F24-6A6D-4F1C-9F43-D9ED9DC80258Q28205358-AC53AF12-6E48-4DA6-B023-EADCCCD941FFQ28207738-E94901AE-B46D-4FA3-AD2A-CEAE457C3DA6Q28209366-C4FA56E0-FC83-4D7A-B529-885414F2CBBDQ28240412-6A03E1E5-7C38-48BC-82D5-2680138B8C1BQ28243737-990A00C9-B18A-4A88-A686-8BE278059DCCQ28245847-14E0D39D-725B-4BCC-B9EB-043374F990C2Q28249115-BCA099FA-C4C8-46B7-974F-4A7DF986323CQ28259868-E5AC3432-8A8F-4AE7-A98C-DD074D6B1191Q28261526-7E6EA148-9CDB-4F57-8994-1E4E696DBD60Q28263662-5F0C4B87-DF93-4CF1-B7D3-ADB13BAC8173Q28269629-B71A8954-9535-46E5-8435-E2D44EA992B9Q28288362-E81BAE19-BA0C-4AE1-9F5C-11743E6BF797Q28296403-4610924F-A6D8-4B1A-9A04-CAB226F7CF62Q28369108-518334DA-B42C-49FA-B1C0-2BE3943AE7D3Q30579578-76F7BBA5-C6B4-48D8-BB1F-DE298194E6FAQ33757903-34211119-52D6-470D-8C12-291920C8B57FQ34979253-F90CB8FA-EB19-45CD-9A51-E43E5E5EB40DQ35116100-67895BE4-C210-4B6A-AC42-A5BC81BEA578Q35873759-BAFB909E-1C4D-48E6-82F9-521AACBD2CCDQ35879854-F23DCBEB-4CF0-4B22-B2B2-B616BF00CA14Q36480080-7B755A3A-759F-47C1-AB4A-56B8AEBFDF03Q36698991-5C9992D6-8720-4CC1-B758-7717F3C0A462Q36756998-A97FEDEB-D7A0-41E0-821B-494AFF0BFFC5Q36796667-D43C3841-CEE2-4CDD-8490-F901E6182E80Q36801998-77BD140E-18CA-474F-A840-541DB15D1B59Q36837270-FF98560B-ECC4-49E1-BDD5-8E17CB5BE8FEQ36874312-22E5CB3F-475D-4614-984A-A1322BD045DDQ36944623-49383255-3876-4419-807C-FAF0CED904F3Q37299072-C83E3F01-EF34-4F4B-9EF4-FE7C4146A576Q37550406-49DAD541-5995-4A22-9C6C-612EACA86CE3Q37702852-6DFA022F-E4D0-490C-BEEA-E64F484D7E7DQ37857290-2DE2C293-B759-4B5C-B16D-F92E69BB6B03Q38025012-4C4E3982-C59C-4A6C-A54A-CF9DE072C168Q38248594-8530A2E8-ADBC-49C1-9D6F-7FC476317411
P2860
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@ast
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@en
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@nl
type
label
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@ast
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@en
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@nl
prefLabel
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@ast
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@en
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@nl
P2093
P1476
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy
@en
P2093
B W Schäfer
C W Heizmann
P Hunziker
P356
10.1016/0167-4889(96)00097-3
P407
P577
1996-10-11T00:00:00Z